CHD Q1 Earnings Beat Expectations, Maintain Neutral Rating, Target Price Raised to $99

Overview

This report is a review and model update by J.P. Morgan on Church & Dwight (CHD)'s 2026 Q1 earnings. The report notes that CHD started the fiscal year strongly, with adjusted earnings per share (EPS) and volume-led organic sales exceeding expectations. Despite additional cost pressures on commodities and transportation due to the Middle East conflict, management reiterated 2026 full-year financial guidance and plans to fully offset these headwinds through productivity improvements, revenue growth management (RGM), and other measures. Accordingly, J.P. Morgan maintains a 'Neutral' rating on CHD and slightly raised the December 2026 target price from $98 to $99.

Core views

Performance Performance and Beat Drivers: CHD's 2026 Q1 adjusted EPS was $0.95, beating J.P. Morgan expectations, market consensus, and company guidance by $0.01, $0.02, and $0.03 respectively. Total organic revenue grew 5% YoY, better than expected 3.0%-3.5%. Main drivers for the beat included higher adjusted gross margin (expanding 130 bps YoY to 46.4%), lower selling, general, and administrative expenses (SG&A), and lower tax rates. Domestic Consumer business performance was particularly outstanding with 5.4% organic growth, while International Consumer and Specialty Products segments grew slightly below expectations. Cost Headwinds and Mitigation Measures: Affected by the Middle East conflict, the company expects full-year headwinds of $25 million to $30 million from new commodity (mainly diesel and resin) and transport costs, which increased originally planned inflation pressure from 160 basis points to approximately 200 basis points. However, management states they will fully offset these impacts through productivity improvements, revenue growth management (RGM), and promo adjustments, considering price hikes on high-end innovative products only in extreme cases. The company hedged approximately 60% of commodity risks early in the year, providing a buffer against pressure. Full Year Guidance and Second Half Outlook: Management reiterated 2026 full-year guidance, including organic sales growth of 3%-4%, margin expansion of 100 basis points, and adjusted EPS growth of 5%-8% ($3.71-$3.81). J.P. Morgan believes that although SG&A was higher in the first half due to Touchland acquisition integration and increased marketing spend leading to flat EPS YoY, EPS is expected to achieve double-digit growth in the second half (expected average YoY growth of 16.8%) as base effects fade and mitigation measures take effect. Investment Logic and Valuation: J.P. Morgan maintains a 'Neutral' rating. Although the company has streamlined its product mix through divestitures of non-core businesses (such as Spinbrush, Vitamin business, etc.) and shifted to a higher proportion of premium products (rising to 64%), beneficial for future financial performance, its growth rate has not yet fully met long-term 'Evergreen' model expectations. Regarding valuation, the new target price of $99 is based on 2027 forecast EPS, calculated using 50% weight of 25.0x PE and 50% weight of 16.4x EV/EBITDA (both historical multiples for CHD in the past year).

Analysis framework

J.P. Morgan's analysis follows a logical framework of 'Performance Verification - Guidance Assessment - Valuation Adjustment'. First, by breaking down key metrics of the Q1 earnings report (EPS, Organic Sales, Gross Margin, SG&A) and comparing expectations with actuals, specific drivers for the beat (such as margin expansion and expense control) are identified. Second, focus is placed on assessing the quantified impact of management's assessment of new cost headwinds (commodities and transport) and the effectiveness of their mitigation strategies, judging the achievability of full-year guidance, particularly distinguishing the performance rhythm between H1 and H2. Finally, combined with the company's long-term strategy of product mix optimization (premiumization, divesting non-core assets), growth potential is compared against long-term algorithmic targets to determine rating stance, and the target price is fine-tuned based on historical valuation multiples. This method emphasizes the balance between short-term performance fluctuations and long-term structural changes.

Methodology notes

• Valuation MethodPE/PEG valuation

  Price-to-Earnings (P/E) Valuation Method

  The report uses 25.0x Price-to-Earnings ratio as one valuation anchor, based on CHD's historical trading multiple for the past year. By multiplying the forecasted EPS by this multiple, it estimates the intrinsic value of the stock, a common relative valuation method in the consumer products industry.

• Valuation MethodEV/EBITDA valuation

  Enterprise Value Multiple (EV/EBITDA) Valuation Method

  The report also uses 16.4x EV/EBITDA as a valuation anchor, also based on CHD's historical multiple. This method eliminates the influence of capital structure and taxes, reflecting the value of corporate operating cash flow more purely, often used in conjunction with the PE method to cross-verify valuation reasonableness.

• Corporate Fundamentals and Financial Framework

  Volume-Price Decomposition and Organic Growth Analysis

  The report breaks down sales revenue growth into 'volume-driven' and 'price/mix-driven', specifically emphasizing the quality of 'organic sales' growth (excluding M&A and currency effects). This helps judge whether growth stems from real market demand (volume) or simply relies on price increases, which is key to assessing the health of consumer products companies.

• Industry/Industrial Analysis Framework

  Product Mix Premiumization and Pricing Power Analysis

  The report focuses on the change in the proportion of 'premium' categories in CHD's product mix (rising from typical 60% to 64%), believing this helps improve overall gross margin and financial performance. This analysis focuses on the strategic effect of the company improving profitability through product structure optimization.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Church & Dwight (CHD US)

  Direct covered asset, earnings beat and steady guidance

  Strengths

  Premium product mix (64% are premium products), volume-driven strong organic growth, strong cost control capabilities, owns successful acquired brands like Hero and TheraBreath

  Weaknesses

  Growth has not yet fully met long-term 'Evergreen' model expectations, higher SG&A pressure in H1, facing commodity cost headwinds

  Comparison

  Outperformed XLP index, but valuation reflects some good news

  Risks

  Declining consumption base, competition intensifying leading to promotions exceeding normal levels, loss of market share

Key data

• Q1 Adjusted EPS$0.95Beat J.P. Morgan expectations by $0.01, beat consensus by $0.02, beat guidance by $0.03
• Q1 Organic Sales Growth+5%Driven by volume, better than expected 3.0%-3.5%
• Q1 Adjusted Gross Margin46.4%Expanded 130 bps YoY, 14 bps better than expected
• New Cost Headwinds$25-30 millionDue to increased commodity and transport costs caused by the Middle East conflict
• 2026 Margin Expansion Guidance+100 basis pointsManagement reiterated, expecting to offset inflation through productivity and mix optimization
• 2026 Adjusted EPS Guidance$3.71-$3.81YoY growth 5%-8%, J.P. Morgan expectation is $3.80
• New Target Price (Dec 2026)$99.00Previously $98.00, based on 25.0x PE and 16.4x EV/EBITDA

Impact & implications

The report believes that CHD's strong start and continuous optimization of product mix (transitioning to premium) provide support for its financial performance. Despite external cost pressures, the company demonstrates strong resilience through internal efficiency improvements and hedging strategies, capable of maintaining the full-year profit margin expansion goal. For investors, this means CHD can still provide stable earnings growth in a volatile market environment, but its excellent year-to-date stock performance (+14.5%) may have already partially priced in this good news, leaving limited upside space, thus maintaining the Neutral rating.

Risks

• Potential decline in consumer demand negatively impacting financial performance
• Intensifying competition or promotional efforts exceeding normal levels
• Loss of market share to competitors
• Commodity and transportation cost headwinds exceed expectations and cannot be fully offset

What to watch

• Whether H2 EPS growth can be achieved as scheduled (expected avg YoY +16.8%)
• Actual impact of new $25-30 million cost headwinds and effectiveness of mitigation measures
• Changes in SG&A and marketing expense ratio after Touchland acquisition integration
• Whether organic sales growth is sustainable, especially performance in Domestic Consumer business